User profiles for Junling Li
Junling LiSoutheast University Verified email at seu.edu.cn Cited by 1512 |
[PDF][PDF] Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification
…, L Li, H Li, X Sheng, C Cui, Z Chi, S Li… - Journal of clinical …, 2011 - researchgate.net
… Corless, Li Li, Haifu Li, Xinan Sheng, Chuanliang Cui, Zhihong Chi, Siming Li, Mei Han,
Lili Mao, Xuede Lin, Nan Du, Xiaoshi Zhang, Junling Li, Baocheng Wang, and Shukui Qin …
Lili Mao, Xuede Lin, Nan Du, Xiaoshi Zhang, Junling Li, Baocheng Wang, and Shukui Qin …
Effect of postoperative radiotherapy for patients with pIIIA-N2 non–small cell lung cancer after complete resection and adjuvant chemotherapy: the phase 3 PORT-C …
…, J Lv, Q Feng, Z Xiao, D Chen, Y Wang, J Li… - JAMA …, 2021 - jamanetwork.com
Importance The role of postoperative radiotherapy (PORT) has not been well defined in resected
pIIIA-N2 non–small cell lung cancer (NSCLC). Objective To evaluate the effect of PORT …
pIIIA-N2 non–small cell lung cancer (NSCLC). Objective To evaluate the effect of PORT …
Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents
…, X Li, W Liu, R Xue, H Wu, DH Shao, J Li, Y Zhou, S Li… - Gut, 2020 - gut.bmj.com
Objective Patients with renal failure suffer from symptoms caused by uraemic toxins, possibly
of gut microbial origin, as deduced from studies in animals. The aim of the study is to …
of gut microbial origin, as deduced from studies in animals. The aim of the study is to …
Drone assisted vehicular networks: Architecture, challenges and opportunities
This article introduces the DAVN, which provides ubiquitous connections for vehicles by
efficiently integrating the communication and networking technologies of drones and connected …
efficiently integrating the communication and networking technologies of drones and connected …
Role of class I and class II histone deacetylases in carcinoma cells using siRNA
KB Glaser, J Li, MJ Staver, RQ Wei, DH Albert… - Biochemical and …, 2003 - Elsevier
The role of the individual histone deacetylases (HDACs) in the regulation of cancer cell
proliferation was investigated using siRNA-mediated protein knockdown. The siRNA for HDAC3 …
proliferation was investigated using siRNA-mediated protein knockdown. The siRNA for HDAC3 …
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor
…, TJ Magoc, LJ Pease, DR Reuter, RQ Wei, J Li… - Molecular cancer …, 2006 - AACR
ABT-869 is a structurally novel, receptor tyrosine kinase (RTK) inhibitor that is a potent inhibitor
of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth …
of members of the vascular endothelial growth factor (VEGF) and platelet-derived growth …
Challenges and coping strategies of online learning for college students in the context of COVID-19: A survey of Chinese universities
J Li, W Che - Sustainable Cities and Society, 2022 - Elsevier
The COVID-19 epidemic has disrupted the normal teaching and learning in universities,
which poses significant challenges to higher education. The traditional face-to-face learning …
which poses significant challenges to higher education. The traditional face-to-face learning …
Discovery of N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-Aminoindazole-Based Orally Active Multitargeted Receptor …
…, CM Harris, D Hickman, J Guo, J Li… - Journal of medicinal …, 2007 - ACS Publications
In our continued efforts to search for potent and novel receptor tyrosine kinase (RTK) inhibitors
as potential anticancer agents, we discovered, through a structure-based design, that 3-…
as potential anticancer agents, we discovered, through a structure-based design, that 3-…
[HTML][HTML] Molecular epidemiology of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology–mainland China subset …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li, G Wu… - PloS one, 2015 - journals.plos.org
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
…, GA Cunha, KB Glaser, J Guo, J Li… - Journal of medicinal …, 2005 - ACS Publications
A series of novel thienopyrimidine-based receptor tyrosine kinase inhibitors has been
discovered. Investigation of structure−activity relationships at the 5- and 6-positions of the …
discovered. Investigation of structure−activity relationships at the 5- and 6-positions of the …